Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Baxter
McKinsey
Merck
Express Scripts

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Heritage Pharma Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for HERITAGE PHARMA, and what generic and branded alternatives to HERITAGE PHARMA drugs are available?

HERITAGE PHARMA has one hundred and five approved drugs.



Summary for Heritage Pharma
US Patents:0
Tradenames:64
Ingredients:62
NDAs:105
Patent Litigation for Heritage Pharma: See patent lawsuits for Heritage Pharma

Drugs and US Patents for Heritage Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharma GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077587-003 Jul 9, 2009 DISCN No No   Start Trial   Start Trial
Heritage Pharma LISINOPRIL lisinopril TABLET;ORAL 075752-006 Jul 1, 2002 DISCN No No   Start Trial   Start Trial
Heritage Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 090402-001 Jul 1, 2010 DISCN No No   Start Trial   Start Trial
Heritage Pharma NADOLOL nadolol TABLET;ORAL 074255-003 Jan 24, 1996 DISCN No No   Start Trial   Start Trial
Heritage Pharma CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087056-001 Approved Prior to Jan 1, 1982 AA RX No Yes   Start Trial   Start Trial
Heritage Pharma GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077587-001 Jul 9, 2009 DISCN No No   Start Trial   Start Trial
Heritage Pharma CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077034-003 Jun 30, 2005 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Merck
Boehringer Ingelheim
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.